Revolutionizing Patient-Centric Supply Chains to Improve Vaccine Access.
Global disruptions over the past several years have had an undeniable impact on the vaccine landscape, including research trends, risk assessment strategies, and supply chain obstacles.
Although vaccines are one of the fastest growing markets in the pharmaceutical industry, they have always come with manufacturing and distribution challenges, and stakeholders must now adapt to accommodate a rapidly growing market with patient-centric supply chains.
You can rely on us for patient-centric supply chains because we are a wholly owned subsidiary of UPS and the essential clinical part of UPS Healthcare. With Marken, BOMI Group and Polar Speed included the UPS Healthcare network staffs 199 locations with 10,000+ employees worldwide.
To read our complete white paper, Revolutionizing Patient-Centric Supply Chains to Improve Vaccine Access, request a copy below.